Biomarcadores para el diagnóstico de infecciones articulares periprotésicas
Biomarkers for the diagnosis of periprosthetic joint infections
DOI:
https://doi.org/10.52379/mcs.v2i1.48Descargas
Los datos de descargas todavía no están disponibles.
Citas
1. Lee YS, Koo KH, Kim HJ, Tian S, Kim TW, Maltenfort MG, et al. Synovial Fluid Bi-omarkers for the Diagnosis of Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. The Journal of Bone and Joint Surgery. 99(24):2077-2084. https://doi.org/10.2106/JBJS.17.00123
2. Parvizi J, Ghanem E, Azzam K, Davis E, Jaberi F, Hozack W. Periprosthetic infection: are current treatment strategies adequate? Acta Orthop Belg. 2008;74(6):793-800. URL.
3. Alvand A, Rezapoor M, Parvizi J. The Role of Biomarkers for the Diagnosis of Implant-Related Infections in Orthopaedics and Trauma. Adv Exp Med Biol. 2017;971:69-79. https://doi.org/10.1007/5584_2017_11
4. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 2014;472(11):3254-3262. https://doi.org/10.1007/s11999-014-3543-8
5. Drago L, Vassena C, Dozio E, Corsi MM, De Vecchi E, Mattina R, et al. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int J Immunopathol Pharmacol 2011;24(2):433-440. https://doi.org/10.1177/039463201102400216
6. Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J. The use of receiver op-erating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 2009;13(6):e444-e449. https://doi.org/10.1016/j.ijid.2009.02.017
7. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res 2009;467(7):1699–1705. https://doi.org/10.1007/s11999-009-0742-9
8. Glehr M, Friesenbichler J, Hofmann G, Bernhardt GA, Zacherl M, Avian A, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 2013;471(8):2621-2628. https://doi.org/10.1007/s11999-013-2998-3
2. Parvizi J, Ghanem E, Azzam K, Davis E, Jaberi F, Hozack W. Periprosthetic infection: are current treatment strategies adequate? Acta Orthop Belg. 2008;74(6):793-800. URL.
3. Alvand A, Rezapoor M, Parvizi J. The Role of Biomarkers for the Diagnosis of Implant-Related Infections in Orthopaedics and Trauma. Adv Exp Med Biol. 2017;971:69-79. https://doi.org/10.1007/5584_2017_11
4. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 2014;472(11):3254-3262. https://doi.org/10.1007/s11999-014-3543-8
5. Drago L, Vassena C, Dozio E, Corsi MM, De Vecchi E, Mattina R, et al. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int J Immunopathol Pharmacol 2011;24(2):433-440. https://doi.org/10.1177/039463201102400216
6. Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J. The use of receiver op-erating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 2009;13(6):e444-e449. https://doi.org/10.1016/j.ijid.2009.02.017
7. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res 2009;467(7):1699–1705. https://doi.org/10.1007/s11999-009-0742-9
8. Glehr M, Friesenbichler J, Hofmann G, Bernhardt GA, Zacherl M, Avian A, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 2013;471(8):2621-2628. https://doi.org/10.1007/s11999-013-2998-3
Descargas
Publicado
08-05-2018
Número
Sección
Cartas al Editor
Licencia
Derechos de autor 2018 Jaime Ibarrola
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
